Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3.145,00 INR | -0,66% | -4,61% | +50,94% |
30/07 | Ajanta Pharma Limited fornisce una guida agli utili per l'anno fiscale 2025 | CI |
30/07 | Transcript : Ajanta Pharma Limited, Q1 2025 Earnings Call, Jul 30, 2024 |
Aggiungi a un elenco 0 selezionato | P/E ratio | Price to Book | PEG | EV/Fatturato | EV / EBITDA | EV / EBIT | Rendimento (Y) | Capi. ($) | |
---|---|---|---|---|---|---|---|---|---|
40.7x | 9,384 | 2.03x | 8.22x | 28.09x | 30.76x | +0.77% | 4,73 Mrd | ||
39.63x | 6,184 | 2.23x | 8.07x | 29.34x | 35.1x | +0.74% | 53,31 Mrd | ||
18.81x | 1,694 | 0.21x | 1.73x | 8.59x | 13.51x | +1.52% | 30,89 Mrd | ||
26.64x | 1,938 | 0.04x | 2.01x | 10.25x | 11.85x | +1.53% | 17,58 Mrd | ||
28.5x | 4,403 | 2.02x | 4.57x | 18.18x | 21.68x | +0.61% | 15,98 Mrd | ||
24.79x | 4,677 | 1.37x | 4.87x | 16.72x | 18.78x | +0.54% | 13,39 Mrd | ||
11.66x | 1,085 | -0.3x | 2.02x | 8.05x | 9.39x | +4.18% | 6,38 Mrd | ||
34.25x | 5,455 | -0.18x | 3.32x | 17.72x | 21.72x | +0.18% | 5,86 Mrd | ||
8.03x | 1,529 | 0.14x | 2.15x | 5.63x | 6.86x | +5.07% | 5,52 Mrd | ||
57.02x | 4,300 | 6.24x | 8.69x | 33.09x | 49.69x | +1.14% | 4,98 Mrd | ||
14.93x | 0,9597 | 1.47x | 2.43x | 9.59x | 12.08x | +1.75% | 4,88 Mrd | ||
13.95x | 1,969 | -5.05x | 1.86x | 7.04x | 8.87x | +5.04% | 4,71 Mrd | ||
35.21x | 8,019 | 1.36x | 9.69x | 28.93x | 32.3x | +1.69% | 3,46 Mrd | ||
23.22x | 3,683 | 1.11x | 2.64x | 12.24x | 16.35x | +0.15% | 3,11 Mrd | ||
15.67x | 1,857 | 0.48x | 1.79x | 8.88x | 11.5x | +2.24% | 1,99 Mrd | ||
Media | 26,20x | 3,81 | 0,88x | 4,27x | 16,16x | 20,03x | +1,81% | 11,78 Mrd | |
Media ponderata per Capi. | 28,90x | 4,07 | 1,17x | 4,81x | 18,35x | 22,62x | +1,35% |
- Borsa valori
- Azioni
- Azione AJANTPHARM
- Settore Ajanta Pharma Limited
- Valutazioni del settore
MarketScreener is also available in this country: United States.
Switch edition